Old Web
English
Sign In
Acemap
>
authorDetail
>
Alejandro Fernandez
Alejandro Fernandez
Takeda Pharmaceutical Company
Medicine
Interim analysis
in patient
Pediatrics
antihemophilic factor
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Final Results of the Prospective ADVATE® Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII.
2021
Journal of Blood Medicine
Amy D. Shapiro
Alejandro Fernandez
Jerome M. Teitel
Jaco Botha
Kate Khair
Show All
Source
Cite
Save
Citations (0)
Effectiveness and Safety Outcomes in Patients with Hemophilia a Receiving Antihemophilic Factor (Recombinant) for at Least 5 Years in a Real-World Setting: 6-Year Interim Analysis of the Ahead International and German Studies
2020
Blood
Dimitrios A. Tsakiris
Johannes Oldenburg
Robert Klamroth
Benoît Guillet
Kate Khair
Angela Huth-Kühne
Karin Kurnik
Stephan Regensburger
Jaco Botha
Alejandro Fernandez
Leilei Tang
Margareth C. Ozelo
Show All
Source
Cite
Save
Citations (1)
1